D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.16
Price History CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 1.06%
30-Day Total Return -14.47%
60-Day Total Return -36.90%
90-Day Total Return -39.20%
Year to Date Total Return -33.13%
1-Year Total Return -11.46%
2-Year Total Return 100.52%
3-Year Total Return 80.66%
5-Year Total Return 199.22%
52-Week High % Change -44.87%
52-Week Low % Change 8.26%
Price CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $62.53
52-Week Low Price $31.84
52-Week Low Price (Date) Feb 25, 2025
52-Week High Price (Date) Nov 14, 2024
Valuation CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 3.21B
Enterprise Value 1.91B
Price/Earnings (TTM) --
Earnings Per Share (TTM) -3.71
Earnings Per Share Growth 0.23%
Price/Earnings To Growth --
Price/Sales (TTM) 3,050.44
Price/Book (Q) 2.42
Enterprise Value/Revenue (TTM) 1,833.53
Price $34.47
Enterprise Value/EBITDA (TTM) -5.67
Enterprise Value/EBIT -5.62
Market Cap Category Mid Cap
Dividends and Shares CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 91.49M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 858 450 6464
Address 6055 Lusk Boulevard San Diego, CA 92121
Website www.crinetics.com
Country United States
Year Founded 2008
Profitability CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -32,613.47%
Profit Margin -28,720.69%
Management Effectiveness CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -20.46%
Return on Equity --
Income Statement CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 1.04M
Total Revenue (TTM) 1.04M
Revenue Per Share $0.01
Gross Profit (TTM) -239.12M
EBITDA (TTM) -336.07M
EBIT (TTM) -338.85M
Net Income (TTM) -298.41M
Net Income Avl. to Common (TTM) -298.41M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -34.11%
EPS Diluted (TTM) -3.71
EPS Diluted Growth (Q YOY) 1.58%
Balance Sheet CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 1.35B
Cash Per Share (Q) $14.80
Total Current Assets (Q) 1.38B
Total Preferred Equity (Q) --
Total Equity (Q) 1.32B
Current Ratio (Q) 23.045
Book Value Per Share (Q) $14.26
Total Assets (Q) 1.43B
Total Current Liabilities (Q) 59.68M
Total Debt (Q) 51.72M
Total Liabilities (Q) 109.79M
Total Common Equity (Q) 1.32B
Cash Flow CRNX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -574.82M
Cash from Financing (TTM) 1.01B
Net Change in Cash (TTM) 209.65M
Levered Free Cash Flow (TTM) -136.41M
Cash from Operations (TTM) -225.97M
Weiss Ratings